Invokana Lawsuit: Side Effects Claimed by Plaintiff to Have Caused the Development of Diabetic Ketoacidosis

April 28, 2016 – – TheProductLawyers.com reports on a lawsuit filed in the Southern District of Alabama under case number 1:15-cv-00636, by a diabetes patient who used Invokana, a new-generation, type 2 diabetes drug. The plaintiff is suing Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson Corporation, alleging that she developed diabetic ketoacidosis shortly after starting to take the drug in December 2014, and that it was caused by her use of Invokana.

Diabetic ketoacidosis is a very dangerous medical condition if not treated immediately in that it can cause diabetic coma and, in some extreme cases, death. The condition arises when there is too much toxic acid in the bloodstream due to the production of ketones. The patient can become symptomatic of ketoacidosis in a very short time, as little as 24 hours. It can sometimes be hard to diagnose at first, which is not comforting to a diabetes patient who may have deal with this condition.

The plaintiff in this particular case claims that she was not informed of this potential risk due to taking the drug and also claims that Janssen Pharmaceuticals was willfully negligent since it did not reveal this information to the public. She also is taking the drug company to task in her lawsuit for not properly studying the impact of the drug on patients and for marketing it “off-label” to treat type 1 diabetes and high blood pressure, which means that the drug was not approved by the US Food and Drug Administration (FDA) for that purpose.

The FDA in a public safety communication expressed concern over this possible potential side effect and has asked patients who may be susceptible to this risk due to taking Invokana or other SGLT2 inhibitor drugs to be cognizant of any symptoms that may arise that may denote the onset of ketoacidosis. As per the Mayo Clinic, symptoms may include confusion, shortness of breath, abdominal pain, frequent urination, excessive thirst, nausea and vomiting, and fruity-scented breath.

For more information about the Invokana lawsuits, or this press release, please contact TheProductLawyers.com on 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009587